Directorate Change

RNS Number : 4300N

JPMorgan China Growth & Income PLC

29 September 2021

JPMORGAN CHINA GROWTH & INCOME PLC

DIRECTORATE CHANGE

Legal Entity Identifier: 549300S8M91P5FYONY25

Information disclosed in accordance with the LR 9.6.13 (1) - (6)

The Board of JPMorgan China Growth & Income plc (the 'Company'), as part of its succession planning, is pleased to announce its intention to appoint Mr. Aditya Sehgal as an independent non-executive Director of the Company with effect from 1st October 2021.

Mr. Sehgal was most recently President of Nutrition, 'eRB' and China with Reckitt - one of the world's largest companies for selfcare, household cleaning and personal care consumer products, with its headquarters in London. He has been on the Group Executive Committee for Reckitt since 2017 till Sep 2021. He became Chief Operating Officer, Health in January 2019 and as part of Reckitt's new business strategy, transitioned to his current role in July 2020.

He is a Director of RB (China Trading) Limited and RB & Manon Business Limited which established a joint venture with Reckitt Benckiser (referred to as 'RB'), Shanghai and other branches in Hong Kong and China.

Mr. Sehgal joined Reckitt in 1994 as a management trainee in India. After various roles in sales and marketing he moved to his first General Manager position in 2009 in China. He was appointed SVP North Asia in 2012 and in 2015 he was promoted to Global Category Officer Health. In 2017, Mr. Sehgal became EVP Infant & Child Nutrition ('IFCN') with responsibility for leading the on-boarding of Mead Johnson into Reckitt and the integration of the IFCN division into Health. In January 2018, he was appointed EVP Health for Developing Markets and Ecommerce.

He has spent several years working in China and has a wealth of experience in marketing, and a particular keen interest in technology and ecommerce-related business in China and globally. The Board believes Mr. Sehgal will be a valuable addition to the Board.

No further information is to be disclosed in respect of paragraphs 9.6.13 (1) - (6) of the UKLA Listing Rules for Mr. Aditya Sehgal.

29th September 2021

For further information, please contact:

Lucy Dina

JPMorgan Funds Limited - Secretary

020 7742 4000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOABSGDCRUDDGBC